HL7 Terminology (THO)
5.5.0 - Continuous Process Integration (ci build) International flag

HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 5.5.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

: null - XML Representation

Active as of 2022-01-14

Raw xml | Download



<NamingSystem xmlns="http://hl7.org/fhir">
  <id value="TNM"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><h3>Summary</h3><table class="grid"><tr><td>Defining URL</td><td>http://terminology.hl7.org/NamingSystem/TNM</td></tr><tr><td>Version</td><td>1.0.0</td></tr><tr><td>Name</td><td>TNM</td></tr><tr><td>Title</td><td>TNM Staging System</td></tr><tr><td>Status</td><td>active</td></tr><tr><td>Definition</td><td><div><p>The TNM Staging System was developed and is maintained by the AJCC and the Union for International Cancer Control (UICC). It is the most commonly used staging system by medical professionals around the world. The TNM classification system was developed as a tool for doctors to stage different types of cancer based on certain, standardized criteria. The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M).</p>
<p>HTA Note: Most content of TNM (V6) is in the SNOMED international release but not content from the most recent (V9).  In Europe many countries use TNM codes, taken from the book and referenced using an OID.</p>
</div></td></tr><tr><td>Publisher</td><td>American Joint Committee on Cancer</td></tr></table><h3>Identifiers</h3><table class="grid"><tr><td><b>Type</b></td><td><b>Value</b></td><td><b>Preferred</b></td><td><b>Period</b></td><td><b>Comment</b></td></tr><tr><td>URI</td><td>https://cancerstaging.org</td><td>true</td><td>2021-11-03 --&gt; (ongoing)</td><td>This is the URL as specified by the terminology owner, and is considered authoritative.</td></tr></table></div>
  </text>
  <extension
             url="http://hl7.org/fhir/5.0/StructureDefinition/extension-NamingSystem.url">
    <valueUri value="http://terminology.hl7.org/NamingSystem/TNM"/>
  </extension>
  <extension
             url="http://hl7.org/fhir/5.0/StructureDefinition/extension-NamingSystem.version">
    <valueString value="1.0.0"/>
  </extension>
  <extension
             url="http://hl7.org/fhir/5.0/StructureDefinition/extension-NamingSystem.title">
    <valueString value="TNM Staging System"/>
  </extension>
  <name value="TNM"/>
  <status value="active"/>
  <kind value="codesystem"/>
  <date value="2022-01-14T00:00:00-00:00"/>
  <publisher value="American Joint Committee on Cancer"/>
  <contact>
    <name
          value="American Joint Committee on Cancer; 633 N. Saint Clair St., Chicago, IL 60611-3211"/>
    <telecom>
      <system value="email"/>
      <value value="ajcc@facs.org"/>
    </telecom>
    <telecom>
      <system value="phone"/>
      <value value="(312) 202-5205"/>
    </telecom>
    <telecom>
      <system value="url"/>
      <value value="https://cancerstaging.org/"/>
    </telecom>
  </contact>
  <responsible value="American Joint Committee on Cancer"/>
  <description
               value="The TNM Staging System was developed and is maintained by the AJCC and the Union for International Cancer Control (UICC). It is the most commonly used staging system by medical professionals around the world. The TNM classification system was developed as a tool for doctors to stage different types of cancer based on certain, standardized criteria. The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M).

HTA Note: Most content of TNM (V6) is in the SNOMED international release but not content from the most recent (V9).  In Europe many countries use TNM codes, taken from the book and referenced using an OID."/>
  <uniqueId>
    <type value="uri"/>
    <value value="https://cancerstaging.org"/>
    <preferred value="true"/>
    <comment
             value="This is the URL as specified by the terminology owner, and is considered authoritative."/>
    <period>
      <start value="2021-11-03"/>
    </period>
  </uniqueId>
</NamingSystem>